Tag: BioNTech News
-
BioNTech Reaches $1.26 Billion Settlement Over COVID-19 Vaccine Royalties
Washington, U.S. – BioNTech (22UAy.DE), the German biotech firm that developed a COVID-19 vaccine in partnership with Pfizer (PFE.N), has resolved royalty disputes with the… Read More
-
Germany’s BioNTech to buy Chinese firm with promising cancer drug
Berlin, Germany – Germany pharmaceutical company BioNTech, which shot to global prominence after its early coronavirus vaccine, has boosted its cancer drug development by agreeing… Read More
